Further, in vitro enzymatic assays, functional assays, and in vivo tumor model suggest that SMAR1 inhibits tumor cell metabolism and tumorigenic properties of cancer cells by suppressing the expression of tumor-associated isoform PKM2 and promoting the expression of enzymatically more efficient PKM1 isoform. The gene discussed is PKM; the disease is neoplasm.